Φορτώνει......
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
BACKGROUND: Despite the prominent position of methotrexate (MTX) in Rheumatoid Arthiris (RA) therapeutics, its real-world effectiveness may be influenced by a relative lack of tolerability or other side effects that physicians may not be aware of but that are bothersome to patients. The aim of this...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Musculoskelet Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037591/ https://ncbi.nlm.nih.gov/pubmed/27669978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1254-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|